Phase 1 trial of vamorolone, a first-in-class steroid, shows improvements in side effects via biomarkers bridged to clinical outcomes
| Image |  |
|---|---|
| Description | scientific article published on 7 March 2018 |
| Author/s |
author: Heather Gordish-Dressman Eric Hoffman Kanneboyina Nagaraju |
| Publication date | March 7, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |